RSS
13 May 2022

Medtronic receives FDA approval for latest generation drug-eluting coronary stent system

Author: admintech | Filed under: Press Release

The Onyx Frontier™ drug-eluting stent offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent DUBLIN, May 13, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today…

This entry was posted on Friday, May 13th, 2022 at 7:15 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»